15642695

Source:http://linkedlifedata.com/resource/pubmed/id/15642695

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005885, umls-concept:C0005910, umls-concept:C0027540, umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0243127, umls-concept:C0262950, umls-concept:C0392747, umls-concept:C0443172, umls-concept:C0443331, umls-concept:C0949691, umls-concept:C1521761, umls-concept:C2003941
pubmed:issue	8
pubmed:dateCreated	2005-7-14
pubmed:abstractText	To determine the changes in body weight, body composition, and bone turnover in patients with spondyloarthropathy (SpA) treated with anti-tumour necrosis factor alpha (TNFalpha).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-10404809, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-10469292, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-10529141, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-10599721, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-11511757, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-11681809, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-12634235, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-12687553, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-12972490, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-1417187, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-14558111, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-1464859, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-14667139, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-1540094, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-1806485, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-3865530, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-7424938, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-7610926, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-7733036, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8200971, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8254032, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8356959, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8371605, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8446301, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8480673, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8670319, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-8970274, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-9159537, http://linkedlifedata.com/resource/pubmed/commentcorrection/15642695-9175935
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0003-4967
pubmed:author	pubmed-author:BrionMM, pubmed-author:DougadosMM, pubmed-author:GarneroPP, pubmed-author:Le HenanffAA, pubmed-author:RouxCC
pubmed:issnType	Print
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1137-40
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:15642695-Absorptiometry, Photon, pubmed-meshheading:15642695-Adult, pubmed-meshheading:15642695-Aged, pubmed-meshheading:15642695-Antibodies, Monoclonal, pubmed-meshheading:15642695-Antirheumatic Agents, pubmed-meshheading:15642695-Body Composition, pubmed-meshheading:15642695-Body Weight, pubmed-meshheading:15642695-Bone Density, pubmed-meshheading:15642695-Drug Administration Schedule, pubmed-meshheading:15642695-Female, pubmed-meshheading:15642695-Follow-Up Studies, pubmed-meshheading:15642695-Humans, pubmed-meshheading:15642695-Insulin-Like Growth Factor I, pubmed-meshheading:15642695-Male, pubmed-meshheading:15642695-Middle Aged, pubmed-meshheading:15642695-Prospective Studies, pubmed-meshheading:15642695-Severity of Illness Index, pubmed-meshheading:15642695-Spondylarthropathies, pubmed-meshheading:15642695-Tumor Necrosis Factor-alpha
pubmed:year	2005
pubmed:articleTitle	Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment.
pubmed:affiliation	Hôpital Cochin, Département de Rhumatologie, 27 rue du Faubourg St Jacques, 75014 Paris, France. christian.roux@cch.ap-hop-paris.fr.
pubmed:publicationType	Journal Article